All research
2026-07-14 PubMed

Disrupting `rcnB` gene in *Acinetobacter baumannii* enhances colistin-mediated killing

Disruption of rcnB modulates colistin susceptibility in Acinetobacter baumannii AB5075.

Background

Acinetobacter baumannii is a critical multidrug-resistant (MDR) pathogen, posing significant therapeutic challenges, particularly with the rise of carbapenem resistance. Colistin, a polymyxin antibiotic, has been reintroduced as a last-resort treatment for these Gram-negative infections. However, the rapid emergence of colistin resistance severely limits its long-term clinical utility. Understanding novel mechanisms that modulate colistin susceptibility is crucial for developing strategies to overcome resistance and enhance the efficacy of this vital antibiotic.

Study Design

Researchers employed a CRISPR-Cas9-based genome editing system to generate an A. baumannii AB5075 ΔrcnB mutant. This allowed for precise gene disruption to investigate the role of rcnB in colistin susceptibility. The study then assessed the impact of rcnB loss on colistin-mediated killing, membrane integrity, oxidative stress defenses, and efflux pump activity. Further mechanistic insights were gained through transcriptomic profiling to identify global stress-response network changes during colistin exposure in the mutant strain.

Results

Loss of the rcnB gene markedly potentiated colistin-mediated killing in A. baumannii AB5075. This enhanced susceptibility was attributed to several associated changes within the bacterium. Specifically, the ΔrcnB mutant exhibited compromised membrane integrity, making it more vulnerable to colistin's action. Furthermore, the disruption of rcnB impaired the bacterium's oxidative stress defenses, reducing its ability to counteract colistin-induced damage. Reduced efflux pump activity was also observed, preventing the bacteria from expelling the antibiotic effectively. Transcriptomic profiling revealed that rcnB deletion profoundly reshaped global stress-response networks, including the suppression of fatty acid biosynthesis and reactive oxygen species (ROS)-detoxifying pathways. Alterations in metal ion and sulfur metabolism were also noted during colistin exposure, further contributing to the enhanced sensitivity.

The disruption of rcnB significantly potentiated colistin-mediated killing through a multifaceted mechanism involving membrane compromise, impaired oxidative stress defenses, and reduced efflux pump activity.

Key Findings

  • rcnB gene disruption markedly potentiated colistin-mediated killing in A. baumannii AB5075.
  • Loss of rcnB compromised bacterial membrane integrity, increasing colistin susceptibility.
  • The ΔrcnB mutant exhibited impaired oxidative stress defenses against colistin.
  • Reduced efflux pump activity was observed in rcnB-deficient A. baumannii.
  • rcnB deletion suppressed fatty acid biosynthesis and ROS-detoxifying pathways.

Why It Matters

These findings offer critical mechanistic insights into colistin resistance and provide a potential new target for enhancing colistin efficacy against MDR A. baumannii. Modulating rcnB activity could represent a novel strategy to resensitize resistant strains to colistin, potentially extending the lifespan of this last-resort antibiotic. For clinicians and researchers, this suggests exploring rcnB as a target for adjunctive therapies that could be co-administered with colistin to improve patient outcomes. While this is an in-vitro study, the detailed mechanistic understanding lays the groundwork for developing targeted small molecules or gene-editing approaches to disrupt rcnB or its associated pathways, moving towards more effective treatment protocols for highly resistant infections.


acinetobacter-baumannii colistin antibiotic-resistance rcnb crispr-cas9 in-vitro
Source: pubmed:42447097 · Ingested 2026-07-14 · Digest: gemini-2.5-flash